Internal Medicine, Nephrology · Fargo, ND
NPI
1053559906
Since 2009
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
736 Broadway N
Fargo, ND, 58122
Phone (701) 234-3360
Groups this clinician bills Medicare through
Medicare paid, 2024
$166K
2,388 services
Medicare patients, 2024
586
Average age 73
Drug cost, 2024
$405K
4,790 prescriptions
Company payments, 2025
$198
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashish V Regulagadda was code 99214 (office e&m - established), 519 times for 326 patients. In total Ashish V Regulagadda billed 2,388 services in 33 codes, and Medicare paid $166K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 519 | 326 | $65.78 | $34K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 303 | 239 | $12.18 | $3,690 |
| 99232 Hospital E&M - Subsequent | Facility | 241 | 119 | $59.44 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 138 | 77 | $89.31 | $12K |
| 90960 ESRD Related Services (not dialysis) | Office | 124 | 22 | $270.03 | $33K |
| 90935 Hemodialysis | Facility | 118 | 50 | $52.83 | $6,234 |
| 90966 ESRD Related Services (not dialysis) | Office | 93 | 17 | $209.09 | $19K |
| 99222 Hospital E&M - Initial | Facility | 91 | 88 | $96.55 | $8,786 |
| 90961 ESRD Related Services (not dialysis) | Office | 74 | 25 | $212.48 | $16K |
| 99214 Office E&M - Established | Office | 46 | 35 | $83.67 | $3,849 |
| 99204 Office E&M - New | Facility | 45 | 45 | $78.38 | $3,527 |
| 99231 Hospital E&M - Subsequent | Facility | 36 | 30 | $36.34 | $1,308 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 26 | $12.58 | $365 |
| 99215 Office E&M - Established | Facility | 24 | 20 | $101.50 | $2,436 |
By year: 2022 $143K for 4,548 services; 2023 $153K for 2,901 services; 2024 $166K for 2,388 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashish V Regulagadda prescribed most often to Medicare patients was Calcitriol, with 887 prescriptions and refills. In total Ashish V Regulagadda wrote 4,790 Medicare prescriptions that cost $405K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 887 | 2,186 | 245 | $19K |
| Furosemide Generic | 556 | 1,190 | 153 | $3,128 |
| Spironolactone Generic | 385 | 845 | 104 | $3,009 |
| Lisinopril Generic | 351 | 813 | 103 | $2,386 |
| Amlodipine Besylate Generic | 245 | 592 | 72 | $1,755 |
| Allopurinol Generic | 219 | 493 | 65 | $2,293 |
| Hydralazine Hcl Generic | 120 | 270 | 34 | $2,056 |
| Losartan Potassium Generic | 110 | 289 | 39 | $1,313 |
| Potassium Chloride Generic | 110 | 219 | 32 | $2,494 |
| Carvedilol Generic | 104 | 233 | 31 | $963 |
| Jardiance Empagliflozin | 98 | 140 | 20 | $81K |
| Hydrochlorothiazide Generic | 81 | 192 | 22 | $403 |
| Sevelamer Carbonate Generic | 80 | 94 | 15 | $7,806 |
| Metoprolol Succinate Generic | 77 | 190 | 21 | $1,387 |
| Tamsulosin Hcl Generic | 64 | 149 | 21 | $859 |
Brand drugs: 349 claims; generic drugs: 4,441 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashish V Regulagadda $198 ($198 in general payments such as food, travel and fees) from 7 companies. The largest payer was CorMedix Inc. with $69.55.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.